Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “De Novo Renal Transplant Recipient.”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00170833
What this trial is testing

Safety, Tolerability and Efficacy of Everolimus With Lower Versus Higher Levels of Tacrolimus in de Novo Renal Transplant Patients

Who this might be right for
Renal Transplantation
Novartis Pharmaceuticals 80
Post-approval studies (Phase 4)Study completedNCT00154232
What this trial is testing

Study to Evaluate the Combination of Enteric-coated Mycophenolate Sodium (EC-MPS), Basiliximab, and C2-monitored Cyclosporine in de Novo Renal Transplant Recipients at Potential High Risk of Delayed Graft Function (DGF)

Who this might be right for
Renal Transplantation
Novartis Pharmaceuticals 46
Testing effectiveness (Phase 2)Study completedNCT00820911
What this trial is testing

Efficacy and Safety of AEB071 Versus Cyclosporine in de Novo Renal Transplant Recipients

Who this might be right for
Kidney Transplantation
Novartis Pharmaceuticals 175
Testing effectiveness (Phase 2)Study completedNCT02970630
What this trial is testing

Envarsus® Once Daily With Everolimus in Elderly Kidney Transplant Recipients: Pharmacokinetic and Clinical Study

Who this might be right for
Kidney Transplantation
Chiesi Farmaceutici S.p.A. 28
Testing effectiveness (Phase 2)Study completedNCT00617604
What this trial is testing

Assess the Efficacy and Safety of Alefacept in Kidney Transplant Recipients

Who this might be right for
De Novo Kidney Transplantation
Astellas Pharma Inc 218
Post-approval studies (Phase 4)Study completedNCT00507793
What this trial is testing

Study Evaluating the Efficacy and Safety of Cyclosporine Reduction in Kidney Transplant Recipients Receiving Sirolimus

Who this might be right for
Kidney Transplantation
Wyeth is now a wholly owned subsidiary of Pfizer 385
Large-scale testing (Phase 3)Study completedNCT00720265
What this trial is testing

Assess the Safety and Efficacy of Prograf and MR4 in Kidney Transplantation Patients

Who this might be right for
Kidney Transplantation
Astellas Pharma Inc 135
Large-scale testing (Phase 3)Study completedNCT00239785
What this trial is testing

Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients

Who this might be right for
Renal Transplantation
Novartis Pharmaceuticals 684
Testing effectiveness (Phase 2)Study completedNCT00504543
What this trial is testing

Efficacy, Safety and Tolerability of AEB071 Versus Cyclosporine in the Novo Renal Transplant Recipients

Who this might be right for
Kidney Transplantation
Novartis Pharmaceuticals 311
Testing effectiveness (Phase 2)Study completedNCT01596062
What this trial is testing

Pharmacodynamics, Efficacy and Safety of Basiliximab 40 or 80 mg in Combination With Ciclosporine Microemulsion or Everolimus, in Adult Low Risk de Novo Renal Transplant Recipients (IDEALE Study)

Who this might be right for
Renal Transplantation
Novartis Pharmaceuticals 16
Large-scale testing (Phase 3)Study completedNCT01079143
What this trial is testing

Progression of Renal Interstitial Fibrosis / Tubular Atrophy (IF/TA) According to Epithelial-mesenchymal Transition (EMT) and Immunosuppressive Regimen (Everolimus Based Versus CNI Based) in de Novo Renal Transplant Recipients

Who this might be right for
Renal Interstitial Fibrosis
Novartis Pharmaceuticals 194
Post-approval studies (Phase 4)Study completedNCT00369161
What this trial is testing

A Twelve-month, Multicenter, Open-label, Randomized Study of the Safety, Tolerability and Efficacy of Everolimus With Basiliximab, Corticosteroids and Two Different Exposure Levels of Tacrolimus in de Novo Renal Transplant Recipients

Who this might be right for
Renal Transplantation
Novartis 228
Post-approval studies (Phase 4)Study completedNCT00862979
What this trial is testing

A Study Investigating the Renal Tolerability, Efficacy, and Safety of a CNI-free Versus a Standard Regimen in de Novo Heart Transplant (HTx) Recipients

Who this might be right for
Heart Transplantation
Novartis Pharmaceuticals 162
Large-scale testing (Phase 3)Ended earlyNCT03995901
What this trial is testing

A Safety and Efficacy Study of FCR001 vs Standard of Care in de Novo Living Donor Kidney Transplantation

Who this might be right for
Transplanted Organ Rejection
Talaris Therapeutics Inc. 15
Large-scale testing (Phase 3)Study completedNCT00239070
What this trial is testing

Extension Study on the Safety and Efficacy of Enteric-coated Mycophenolate Sodium in Kidney Transplant Recipients

Who this might be right for
Renal Transplantation
Novartis 69
Post-approval studies (Phase 4)Study completedNCT00266123
What this trial is testing

Study Comparing Two Sirolimus Regimens vs. Tacrolimus and Mycophenolate Mofetil Regimen in Kidney Transplant Recipients

Who this might be right for
Graft RejectionKidney FailureKidney Transplant
Wyeth is now a wholly owned subsidiary of Pfizer 420
Large-scale testing (Phase 3)Study completedNCT00149903
What this trial is testing

Study of Enteric-coated Mycophenolate Sodium Versus Mycophenolate Mofetil in Adult de Novo Renal Transplant Patients

Who this might be right for
Renal Transplant
Novartis Pharmaceuticals 300
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06751602
What this trial is testing

Belumosudil for Abrogation of Interstitial Fibrosis and Tubular Atrophy Following Kidney Transplantation

Who this might be right for
Rejection Chronic Renal
The Methodist Hospital Research Institute 40
Testing effectiveness (Phase 2)Study completedNCT01064791
What this trial is testing

Efficacy, Safety, Tolerability, and Pharmacokinetics of Sotrastaurin Combined With Tacrolimus vs. a Mycophenolic Acid-tacrolimus Regimen in Renal Transplant Patients

Who this might be right for
Renal Transplantation
Novartis Pharmaceuticals 298
Not applicableUnknownNCT04414735
What this trial is testing

Impact of Photopheresis in the Prevention of Acute Rejection in Highly Sensitized de Novo Kidney Transplant Recipients

Who this might be right for
Kidney Transplant Rejection
Fundacion Clinic per a la Recerca Biomédica 30
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation